GlassScriptPhysician profile
Leslie J Salomone
NPI 1811937758
$1,446.38
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $699 · 2021: $156.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $322.26 | 2019-2021 | |
| Dexcom, INC. | $296.19 | 2019-2020 | |
| Insulet Corporation | $294.09 | 2019-2020 | |
| Novo Nordisk INC | $111.27 | 2019-2021 | |
| Horizon Therapeutics Plc | $68.58 | 2020-2021 | |
| Mannkind Corporation | $58.39 | 2019-2020 | |
| Amarin Pharma, INC. | $48.19 | 2020 | |
| Merck Sharp & Dohme LLC | $45.15 | 2019-2020 | |
| Amgen INC. | $35.31 | 2019-2020 | |
| Ibsa Pharma INC. | $30.97 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $24.68 | 2020 | |
| Antares Pharma, INC. | $20.20 | 2020 | |
| Lilly USA, LLC | $20.13 | 2021 | |
| Medtronic, INC. | $17.26 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.26 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $15.02 | 2020 | |
| Pfizer INC. | $12.37 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Salomone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.